Connect with us

Media OutReach

Johnson & Johnson and Asia Pacific Patient Advocacy Group Leaders Unite to Strengthen Shared Decision-Making in Lung Cancer Care

Published

on

Patient survey finds that those engaged in shared decision-making were 11 times more likely to report higher satisfaction with their treatments, with 90% of lung cancer patients in Japan wanting to play an active role in their treatment decisions[1]

J&J deepens its commitment to patient empowerment in Asia Pacific by launching J&J withMe, a new patient portal offering tailored patient resources, and co-driving market-specific initiatives with patient advocacy groups

SINGAPORE – Media OutReach Newswire – 11 December 2025 – Johnson & Johnson announced the next phase of The 3rd Opinion campaign across Asia Pacific, focused on championing shared decision-making between lung cancer patients and healthcare professionals through events and stakeholder engagements at ESMO Asia 2025 in Singapore.

At a Patient Reception on 6th December 2025, 20 leaders from 17 patient advocacy groups from across Asia Pacific, Europe and the United States shared their support for the need to strengthen shared decision-making. On December 7, 2025, the ESMO Asia 2025 Symposium, ‘Advancing EGFRm NSCLC Treatment Through Shared Decision-Making’ highlighted the role of healthcare professionals not only in making sense of the data but also in helping patients and their families navigate complex decision-making.

“High prevalence in Asia of certain NSCLC mutations makes the choice of first-line therapy absolutely critical. Treatment decisions must balance clinical objectives with patient values — weighing disease biology, survival prospects, durable disease control and the tradeoffs of side effects. That’s why shared decision-making is essential: clinicians should present all appropriate treatment options, so the final choice is collaborative and aligned with each patient’s goals,” said Professor Zhu Zhengfei, Director of the Radiation Oncology Department, Fudan University Shanghai Cancer Center.

“When lung cancer patients are empowered to speak up and understand their options, they are more likely to continue the treatment and their dignity is preserved. Initiatives like ‘The 3rd Opinion’ are vital for fostering truly patient-centered partnerships between people living with cancer and their healthcare teams,” noted Ms. Liu Yiting, Marketing & Branding Director, China MeetHealth Mi-Jian Patient Community.

“The shared commitment validates what many people living with lung cancer have long expressed: shared decision making is essential. From our experience supporting patients, meaningful conversations with clinicians help acknowledge patients’ experiences, address their concerns, and preserving their hopes,” added Mr. Jung-Il Cho, Chairman of Korea Lung Cancer Patients Association.

Our commitment comes off the back of a recent patient survey revealing that 90% of Japanese lung cancer patients want to play an active role in their treatment decisions. The survey also found that shared decision-making, where physicians and patients jointly compare treatment options and decide together, is the strongest driver of treatment satisfaction.1

Patient survey finds that those engaged in shared decision-making were 11 times more likely to report higher satisfaction with their treatments, with 90% of lung cancer patients in Japan wanting to play an active role in their treatment decisions. This finding underscores the importance of shared decision-making and patient-centered care.1

To bridge the gap between patients’ desire to engage in shared decision making and their lack of practical support, J&J has launched “J&J withMe”, an online hub that equips lung cancer patients and caregivers with tailored toolkits and conversation guides to prepare for consultations and make informed, personalized treatment decisions.

Anthony Elgamal, Vice President of Oncology, Johnson & Johnson Innovative Medicine Asia Pacific said, The 3rd Opinion truly puts patients at the center of care. As part of our deep commitment to address patients’ unmet needs, we will continue partnering with patient advocacy groups and healthcare professionals to help patients to find their voice and the moment when medical advice meets what truly matters to patients.”

图像 (3)

In recognition of diverse cultural and clinical norms across Asia Pacific, J&J has also rolled out tailored market activations in collaboration with local patient advocacy groups:

  • Provision of patient resources such as the “Lung Cancer Book of Answers” in China, ‘Value of Time’ video for patients in Japan, and educational assets in India and Australia/New Zealand;
  • Digital and social media engagement featuring patients and creators discussing the importance of shared decision-making across Singapore, Malaysia, Philippines, Thailand, and Vietnam;
  • Event engagement via the establishment of a patient advisory board in India;
  • Corporate Social Responsibility program with a lung cancer patient group in Korea, bringing employees and patients together to better understand the disease burden of patients and strengthen emotional support for the patient community.

###

About the 3rd Opinion

“The 3rd Opinion”, the patient’s own opinion, is a new term that sparks a social movement in the lung cancer treatment journey – designed to elevate the patient voice and empower individuals to take an active role in shaping their treatment plan. By prioritizing shared decision-making between patients and healthcare professionals, this collaborative approach ensures that treatment choices are aligned to each patient’s goals, preferences and circumstances. This results in more informed decisions, greater patient satisfaction, and the best possible outcomes.

About Non-Small Cell Lung Cancer

Worldwide, lung cancer is one of the most common cancers, with NSCLC making up 80 to 85 percent of all lung cancer cases.[1], [2] The main subtypes of NSCLC are adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.[3] Among the most common driver mutations in NSCLC are alterations in EGFR, which is a receptor tyrosine kinase controlling cell growth and division.[4] EGFR mutations are present in 10 to 15 percent of Western patients with NSCLC with adenocarcinoma histology and occur in 40 to 50 percent of Asian patients.[5], [6],[7],[8],[9],[10] EGFR ex19del or EGFR L858R mutations are the most common EGFR mutations.[11] The five-year survival rate for all people with advanced NSCLC and EGFR mutations treated with EGFR tyrosine kinase inhibitors (TKIs) is less than 20 percent.[12],[13] EGFR exon 20 insertion mutations are the third most prevalent activating EGFR mutation.[14] Patients with EGFR exon 20 insertion mutations have a real-world five-year overall survival (OS) of eight percent in the frontline setting, which is worse than patients with EGFR ex19del or L858R mutations, who have a real-world five-year OS of 19 percent.[15]By comparison, other common cancers, such as breast and prostate cancer have a 5-year real world OS of 90% and 97% respectively[16].


[1] Johnson & Johnson lung cancer patient quantitative survey conducted in Japan, 2025

[2] The World Health Organization. Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed March 2025.

[3] American Cancer Society. What is Lung Cancer? https://www.cancer.org/content/cancer/en/cancer/lung-cancer/about/what-is.html. Accessed March 2025.

[4] Oxnard JR, et al. Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions. J Thorac Oncol. 2013 Feb;8(2):179-84. doi: 10.1097/JTO.0b013e3182779d18.

[5] Bauml JM, et al. Underdiagnosis of EGFR Exon 20 Insertion Mutation Variants: Estimates from NGS-based Real World Datasets. Abstract presented at: World Conference on Lung Cancer Annual Meeting; January 29, 2021; Singapore.

[6] The World Health Organization. Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed March 2025.

[7] American Cancer Society. What is Lung Cancer? https://www.cancer.org/content/cancer/en/cancer/lung-cancer/about/what-is.html. Accessed March 2025.

[8] Pennell NA, et al. A phase II trial of adjuvant erlotinib in patients with resected epidermal growth factor receptor-mutant non-small cell lung cancer. J Clin Oncol. 37:97-104.

[9] Burnett H, et al. Epidemiological and clinical burden of EGFR exon 20 insertion in advanced non-small cell lung cancer: a systematic literature review. Abstract presented at: World Conference on Lung Cancer Annual Meeting; January 29, 2021; Singapore.

[10] Zhang YL, et al. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget. 2016;7(48):78985-78993.

[11] Midha A, et al. EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity. Am J Cancer Res. 2015;5(9):2892-2911.

[12] American Lung Association. EGFR and Lung Cancer. https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/symptoms-diagnosis/biomarker-testing/egfr. Accessed March 2025.

[13] Howlader N, et al. SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site.

[14] Lin JJ, et al. Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs. J Thorac Oncol. 2016 Apr;11(4):556-65

[15] Arcila, M. et al. EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics. Mol Cancer Ther. 2013 Feb; 12(2):220-9.

[16] Girard N, et al. Comparative clinical outcomes for patients with NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations. Abstract presented at: World Conference on Lung Cancer Annual Meeting; January 29, 2021; Singapore.

[17] Surveillance, Epidemiology, and End Results (SEER) Program, National Cancer Institute, 2024.

Hashtag: #Johnson&Johnson

The issuer is solely responsible for the content of this announcement.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at or at . Follow us at .

Johnson & Johnson Innovative Medicine Asia Pacific, a division of Johnson & Johnson International (Singapore) Pte. Ltd is a Johnson & Johnson company.

© Johnson & Johnson International (Singapore) Pte. Ltd. [2025] All rights reserved.

Media OutReach

From Mexico to Hong Kong, Jose Manuel Cervantes Sanchez is Building Bridges Through Media at CUHK

Published

on

HONG KONG SAR – Media OutReach Newswire – 24 July 2026 – As the media industry becomes increasingly global and interconnected, students are seeking education that spans cultures and markets. For Jose Manuel Cervantes Sanchez, a scholarship recipient from Mexico, The Chinese University of Hong Kong (CUHK) offers a platform to do exactly that.

Jose Manuel Cervantes Sanchez is Building Bridges Through Media at CUHK

Hong Kong: A Strategic Hub for Global Media

Currently enrolled in CUHK’s Global Communication programme, Jose is part of a growing wave of international students choosing Hong Kong for its strategic role as a cultural and commercial gateway between East and West. Long fascinated by Asian culture and influenced by family ties to the city, he was drawn to its unique position as a bridge between cultures. “I wanted to become a local with time and create bridges between Mexico and Hong Kong,” he said.

A school adviser first introduced him to CUHK as a strong option, and while he also considered universities in Canada and the United Kingdom, Hong Kong remained his first choice. Receiving the CUHK University Admission Scholarship confirmed his decision.

Academic Excellence and Creative Exploration

Jose’s experience in the Global Communication programme has met his expectations and more. What stands out most to him are the creative courses, which give students hands-on access to professional media equipment and the freedom to experiment. “Being encouraged to explore creativity by some professors has led me to discover new sides of myself,” he noted.

Outside the classroom, Jose has embraced life in Hong Kong with enthusiasm. From cultural events and student society gatherings to exploring local food streets, he has found the city lively and inspiring. The campus MTR station also makes it easy to travel to Shatin, Hong Kong Island, and even the Shenzhen border, adding to the convenience of student life.

A Creative Career Taking Shape in Hong Kong

Looking ahead, Jose hopes to take part in a semester exchange and a media production internship to further strengthen his practical skills. His post-graduation plans remain open, with possibilities in both Mexico’s rapidly growing entertainment industry and Hong Kong’s dynamic market.

For international students considering their options, Jose’s message is clear: CUHK offers academic quality, financial support, and a valuable foothold in one of the world’s most dynamic cities.

CUHK’s Global Communication Programme

CUHK’s Global Communication programme prepares students for an evolving media landscape by combining communication studies with a guaranteed overseas exchange and a curriculum built around real-world experience.

  • Cutting-Edge Facilities: Access to a 4K-UHD Virtual Set Studio, Digital Radio Studio, and VR Lab.
  • Guaranteed Global Exchange: One semester at a partner university in Asia, Europe, or North America.
  • Hands-On Learning: Real-world experience through journalism projects and overseas study tours.
  • International Classroom: A 1:1 ratio of international to local students with all courses taught in English.

For more information about CUHK’s Global Communication programme, visit https://admission.cuhk.edu.hk/programme/gcomn/
Hashtag: #CUHK

The issuer is solely responsible for the content of this announcement.

Continue Reading

Media OutReach

Singapore’s Largest Pet Event Returns Bigger Than Ever with Singapore Pet Festival 2026

Published

on

Featuring Cesar Millan’s Singapore Debut, Over 300 Exhibitors, 800+ Brands, International Competitions, and Four Halls of Pet Experiences

SINGAPORE – Media OutReach Newswire – 24 July 2026 – Pet lovers can look forward to the return of SG Pet Festival 2026, Singapore’s largest pet exhibition, happening from 31 July to 2 August 2026 at Marina Bay Sands Convention Centre, Halls A, B, C & D.

Spanning across four exhibition halls, this year’s festival promises its biggest edition yet, bringing together over 300 exhibitors representing more than 800 local and international brands. Visitors can expect an exciting three-day celebration filled with shopping, education, competitions, interactive experiences, exclusive launches, and entertainment for pets and their families.

“Singapore Pet Festival has always been about bringing the pet community together while creating opportunities for brands, businesses, and pet lovers to connect. As the festival continues to grow, we are committed to raising industry standards, supporting education, and introducing new experiences that benefit both consumers and businesses. This year’s festival is our biggest and most exciting edition yet, and we look forward to welcoming everyone to Marina Bay Sands,” said Angie Lim, Managing Director of Citrus Media.

Event Highlights

Cesar Millan Makes His Singapore Debut
One of this year’s biggest highlights is the highly anticipated Singapore debut of world-renowned dog behaviour expert Cesar Millan.
Visitors can look forward to exclusive live sessions, stage appearances, and limited-capacity private workshops. For just $98 per session, pet owners can enjoy an intimate learning experience, gaining practical insights into dog behaviour, training techniques, and the opportunity to learn directly from the world-famous “Dog Whisperer.”
Fans can also choose from specially curated experience packages. The $68 Meet & Greet Package includes a photo with Cesar and a live autograph session, where he will sign the exclusive collectible merchandise included with your ticket. Collectors can also purchase the Exclusive Cesar Millan Collector’s Pack for $50 during the Early Bird promotion, available until 30 July. The pack includes a pair of autographed coasters.

Shop, Save & Win

Visitors can enjoy:

  • $30,000 worth of Cash Rebates & Lucky Draw Prizes
  • Exclusive event-only product launches, promotions, and deals
  • Official TikTok LIVE shopping sessions featuring exclusive festival promotions and participating exhibitors
  • Complimentary Limited Edition Singapore Pet Festival Tote Bag (while stocks last)
  • Complimentary themed photobooth print-outs for qualifying spenders
  • Exclusive giveaways and brand activations throughout the festival

Singapore’s Largest Pet Marketplace

With over 300 exhibitors showcasing 800+ brands, visitors can explore the latest products and services for dogs, cats, birds, small animals, aquatics, and more.
A specially curated Food Street featuring 18 food booths will also offer a delicious selection of food, refreshing beverages, and indulgent desserts, giving visitors plenty of dining options throughout the festival.

International & Industry Highlights

Singapore Pet Festival continues to strengthen its position as a leading regional pet event by welcoming exhibitors and industry professionals from across Asia.

Highlights include:

  • International exhibitors from across Asia, including the Japan Pavilion and Korea Pavilion
  • Singapore’s first International Society of Canine Cosmetologists (ISCC) Grooming Certification & Competition
  • The 8th TICA Cat Show, featuring pedigreed cats and renowned breeders
  • National Dog Obedience Competition, featuring Singapore’s top obedience teams in a live showcase of skill and teamwork supported by Pets Enterprises & Traders Association Singapore (PETAS)
  • International judging panels and industry experts

Dedicated Experiences for Every Pet Lover

Visitors can enjoy:

  • A dedicated Hall D for Cats & Small Animals, showcasing curated brands, activities, and live animal displays, including birds, guinea pigs and chinchillas
  • Interactive pet-friendly activities and experiences
  • Exclusive themed pet photo shoot experiences

Education & Community

Beyond shopping, Singapore Pet Festival aims to educate and connect the pet community through:

  • Educational talks, workshops, and live demonstrations
  • Meet-and-greet opportunities with veterinarians, trainers, groomers, and industry professionals
  • Animal welfare groups hosting on-site adoption drives, giving rescued animals the opportunity to find loving forever homes while promoting responsible pet adoption
  • A platform connecting pet owners, businesses, and animal lovers across the region

Exclusive Media Preview

Ahead of the public opening, invited media representatives, content creators, VIP guests and industry partners will enjoy exclusive early access to Singapore Pet Festival 2026 during the VIP Preview Session on Friday, 31 July, from 10:00 AM.

The preview offers creators a first-hand shopping experience, early access to new product launches and exclusive deals, opportunities to create content before the crowds arrive, and networking with brands and fellow creators.

Hashtag: #clubpets #sgpetfestival #petevents #petexpo #petfair




The issuer is solely responsible for the content of this announcement.

About Singapore Pet Festival

Organised by Citrus Media, Singapore Pet Festival is Singapore’s largest pet exhibition, bringing together pet owners, businesses, brands, professionals, and animal lovers under one roof. Through education, innovation, community engagement, and meaningful collaborations, the festival continues to promote responsible pet ownership while supporting the growth of the regional pet industry.

About Citrus Media

Citrus Media Pte Ltd is a Singapore-based events and media company dedicated to connecting communities through innovative exhibitions, digital media, and lifestyle platforms. The company is the organiser of flagship events including Singapore Pet Festival (SGPF), Singapore Cat Carnival, Blissful One-Stop Wedding Show (BOWS), and operates the Clubpets ecosystem, comprising Clubpets Marketplace, VIPaws Membership Programme, and digital media channels. Citrus Media is committed to creating meaningful experiences that bring together consumers, brands, and industry partners.

Continue Reading

Media OutReach

Escape the Heat: Journey from Vietnam to Guizhou’s 23°C Summer Paradise

Published

on

GUIZHOU, CHINA – Media OutReach Newswire – 24 July 2026 – As July brings scorching heat to Vietnam, Guizhou enjoys a refreshing breeze. Recently, a group of Vietnamese travel merchants and tourism influencers landed at Guiyang Longdongbao International Airport, embarking on a journey to explore Guizhou. Known as a “Green Kingdom” steeped in natural beauty and rich culture, Guizhou is redefining summer travel for Vietnamese tourists with its cool 23°C climate, world-class landscapes, and vibrant local lifestyle.

Link: https://www.youtube.com/watch?v=SwgVyMKMj2M

Spectacular Mountain Scenery, Natures Air Conditioner

From the dazzling urban energy of Guiyang’s Qingyun Market to the starry nightscape of Xijiang Qianhu Miao Village, and from the majestic Huangguestu Waterfall to the sky-high Huajiang Canyon Bridge—the “world’s highest bridge”—every corner of Guizhou is a masterpiece worth pausing for.

“Guizhou’s summer feels like natural air conditioning,” shared a young Vietnamese travel influencer. “The seamless blend of daytime nature and vibrant city life made our journey incredibly exciting and fulfilling”

Link: https://www.guizhoutravel.com/feature/list

Immersive Culture & Play your way Through Guizhou

During their trip, the influencers dressed in exquisite traditional Miao costumes for stunning social media photos against the backdrop of historic wooden stilt houses. They also explored urban landmarks like Qingyun Market and Colorful Guizhou Town, experiencing the fusion of local heritage and modern trends amidst neon lights and bustling night markets. Food-wise, local delicacies like sour fish soup, beef rice noodles, and Siwawa (veggie wraps) continuously delighted their palates, offering a perfect mix of cultural depth and trendy adventures.

Pack your bags and go: Effortless Travel to Your Next Getaway

With direct flights now operating from Hanoi and Ho Chi Minh City to Guiyang—taking just over three hours—traveling to Guizhou has never been easier. Supported by China’s 240-hour visa-free transit policy and a safe, welcoming environment, Guizhou is becoming the ideal and ultimate “summer escape” destination for young Vietnamese travelers.

Guizhou is actively building a world-class tourism product system tailored for the international market, centering on the core themes of “Summer Escape + Eco-tourism + Cultural Experience.”

Pack your bags this summer and embark on your own adventure to mystical Guizhou!

Discover more of mystical Guizhou: www.guizhoutravel.com

Hashtag: #Guizhou #Vietnam #SummerEscape

The issuer is solely responsible for the content of this announcement.

Continue Reading